HLN - MCAP CO - Haleon plc

Haleon plc (HLN) produces consumer healthcare products. This historical price chart illustrates the impact of geopolitics on raw material logistics from Asia and margins due to currency fluctuations, with a market capitalization of 40.97. The asset retains its defensive qualities, as demand for hygiene products and over-the-counter medicines remains stable. Brand loyalty is driven by globally recognized products with proven efficacy.

The market capitalization of Haleon plc (HLN), which has reached 40.97, represents the product of the current share price and the total number of outstanding shares, reflecting the aggregate market value of all the company's equity. The dynamics of this indicator allow for an assessment of the business's resilience against the expansion of low-cost private labels and confirm the fundamental value of the global over-the-counter portfolio in the eyes of investors.